Consensus guidelines for the management of adult high-grade gliomas for low and middle-income countries
Syed Ather Enam,Hafiza Fatima Aziz,Saqib Kamran Bakhshi,Ahmed Altaf,Kaynat Siddiqui,Asim Hafiz,Adeeba Zaki,Muhammad Osama,Ahmed Gilani,Pakistan Brain Tumour Consortium,Muhammad Abbas Khokhar,Muhammad Tariq,Amjad Ali Qureshi,Muhammad Tariq Khan,M Shahzad Shamim,Farrukh Javeed,Riaz Ahmed Raja Memon,Ahsan Tariq Khan,Faiqa Filza,Manzoor Ahmad,Muhammad Abid Saleem,Muhammad Arshad,Ahmed Nadeem Abbasi,Muhammad Nadeem,Naveed Ashraf,Nasir Raza Awan,Asghar Hussain Asghar,Rashid Jooma,Maqsood Akram,Asif Bashir,Naqib Ullah Achakzai,Shahid Ayub,Muhammad Asim Khan Rehmani,Kamran Saeed,Naveed Zaman Akhunzada,Abdul Sattar M Hashim,Muhammad Mehboob Alam,Shahzad Shams,Talha Abbas,Ahmed Ali Shah,Sumera Butt,Zaeem Sultan,Syed Ahmer Hamid,Nadeem Akhtar,Bilal Khan,Altaf Ali Laghari,Muhammad Usman,Khalid Mahmood,Saad Akhtar Khan,Akhtar A Zahid,Mazhar Ali Shah,Irfan Yousaf,Salman Sharif,Arif Jamshed,Tariq Mahmood,Mumtaz Ali,Saad Bin Anis,Qurat Ul Ain Tariq,Yaseen Rauf,Tahir Shahab,Bushra Ahmad,Manzar Hussain,Syed Sarmad Bukhari,Muhammad Atif Mansha,Muhammad Shakir,Muhammad Ehsan Bari,Gohar Javed,Faizuddin Najmuddin
DOI: https://doi.org/10.47391/JPMA.S3.GNO-12
Abstract:High-grade glioma (HGG), a formidable and often incurable disease, presents an even greater challenge in low- and middle-income countries (LMICs) where resources and medical expertise are scarce. This scarcity not only exacerbates the suffering of patients but also contributes to poorer clinical outcomes. Particularly in LMICs, the underrepresentation of the population in clinical trials and the additional hurdles posed by financial constraints underscore an urgent need for contextspecific management strategies. In response, we have rigorously evaluated recent guidelines from leading medical societies, adapting them to suit the specific needs and limitations of the local context in Pakistan. This effort, undertaken in collaboration with local physicians, aims to provide a comprehensive, standardised approach to diagnose, treat, and follow-up with HGG patients. By focussing on the best available clinical evidence and judicious use of limited resources, we strive to improve patient care and outcomes in these challenging settings.